Kezar Life Sciences
KZR
NASDAQ
IPO2018
about KZR
Kezar Life Sciences is a biotechnology company focused on developing innovative treatments for various diseases, with an emphasis on immuno-oncology.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $5.66 | $6.40 | $5.63 | $46.57M | 5.96M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$2.27 | n/a | n/a | 0% | 0% | 0% |